M Ilhan1, N O Tiryakioglu2, O Karaman3, E Coskunpinar4, R S Yildiz5, S Turgut5, D Tiryakioglu6, H Toprak7, E Tasan3. 1. Department of Endocrinology and Metabolism, Bezmialem University, Vatan Caddesi, 34093, Istanbul, Turkey. muzoilhan@yahoo.com. 2. Department of Molecular Biology and Genetics, Halic University, Istanbul, Turkey. 3. Department of Endocrinology and Metabolism, Bezmialem University, Vatan Caddesi, 34093, Istanbul, Turkey. 4. Division of Medical Genetics, Department of Internal Medicine, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey. 5. Department of Internal Medicine, Bezmialem University, Vatan Caddesi, 34093, Istanbul, Turkey. 6. Department of Basic Oncology, Oncology Institute, Istanbul University, Istanbul, Turkey. 7. Department of Radiology, Bezmialem University, Vatan Caddesi, 34093, Istanbul, Turkey.
Abstract
PURPOSE: Familial neurohypophyseal diabetes insipidus (FNDI) is a rare, autosomal dominant, inherited disorder which is characterized by severe polydipsia and polyuria generally presenting in early childhood. In the present study, we aimed to analyze the AVP gene in a Turkish family with FNDI. METHODS: Four patients with neurohypophyseal diabetes insipidus and ten healthy members of the family were studied. Diabetes insipidus was diagnosed by the water deprivation test in affected family members. Mutation analysis was performed by sequencing the whole coding region of AVP-NPII gene using DNA isolated from peripheral blood samples. RESULTS: Urine osmolality was low (<300 mOsm/kg) during water deprivation test, and an increase more than 50 % in urine osmolality and recovery of the symptoms were observed by the administration of desmopressin in all patients. Plasma copeptin levels were lower than expected according to plasma osmolality. Pituitary MRI revealed partial empty sella with a bright spot in index patient and a normal neurohypophysis in the other affected subjects. Genetic screening revealed a novel, heterozygous mutation designated as c.-3A>C in all patients. CONCLUSION: c.-3A>C mutation in 5'UTR of AVP gene in this family might lead to the truncation of signal peptide, aggregation of AVP in the cytoplasm instead of targeting in the endoplasmic reticulum, thereby could disrupt AVP secretion without causing neuronal cytotoxicity, which might explain the presence of bright spot. The predicted effect of this mutation should be investigated by further in vitro molecular studies.
PURPOSE:Familial neurohypophyseal diabetes insipidus (FNDI) is a rare, autosomal dominant, inherited disorder which is characterized by severe polydipsia and polyuria generally presenting in early childhood. In the present study, we aimed to analyze the AVP gene in a Turkish family with FNDI. METHODS: Four patients with neurohypophyseal diabetes insipidus and ten healthy members of the family were studied. Diabetes insipidus was diagnosed by the water deprivation test in affected family members. Mutation analysis was performed by sequencing the whole coding region of AVP-NPII gene using DNA isolated from peripheral blood samples. RESULTS: Urine osmolality was low (<300 mOsm/kg) during water deprivation test, and an increase more than 50 % in urine osmolality and recovery of the symptoms were observed by the administration of desmopressin in all patients. Plasma copeptin levels were lower than expected according to plasma osmolality. Pituitary MRI revealed partial empty sella with a bright spot in index patient and a normal neurohypophysis in the other affected subjects. Genetic screening revealed a novel, heterozygous mutation designated as c.-3A>C in all patients. CONCLUSION: c.-3A>C mutation in 5'UTR of AVP gene in this family might lead to the truncation of signal peptide, aggregation of AVP in the cytoplasm instead of targeting in the endoplasmic reticulum, thereby could disrupt AVP secretion without causing neuronal cytotoxicity, which might explain the presence of bright spot. The predicted effect of this mutation should be investigated by further in vitro molecular studies.
Authors: E Cacciari; S Zucchini; G Carlà; P Pirazzoli; A Cicognani; M Mandini; M Busacca; C Trevisan Journal: Arch Dis Child Date: 1990-11 Impact factor: 3.791
Authors: Theron A Russell; Masafumi Ito; Mika Ito; Richard N Yu; Fred A Martinson; Jeffrey Weiss; J Larry Jameson Journal: J Clin Invest Date: 2003-12 Impact factor: 14.808
Authors: Yong-Wha Lee; Kyung Wook Lee; Ji Won Ryu; Ji Oh Mok; Chang-Seok Ki; Hyeong Kyu Park; Yeo Joo Kim; Sang Jin Kim; Dong Won Byun; Kyo Ill Suh; Myung Hi Yoo; Hee Bong Shin; You Kyoung Lee; Chul-Hee Kim Journal: Ann Clin Lab Sci Date: 2008 Impact factor: 1.256
Authors: Peter D Stenson; Matthew Mort; Edward V Ball; Katy Shaw; Andrew Phillips; David N Cooper Journal: Hum Genet Date: 2014-01 Impact factor: 4.132
Authors: Gabriela Hrčková; Viktor Jankó; Jitka Kytnarová; Michaela Čižmárová; Markéta Tesařová; Ľudmila Košťálová; Daniela Virgová; Tomáš Dallos; Václav Hána; Jan Lebl; Jiří Zeman; László Kovács Journal: Eur J Pediatr Date: 2016-08-18 Impact factor: 3.183